Observational study to investigate the intraocular pressure reduction effect by 0.4% Ripasudil after trabectome

Observational study to investigate the intraocular pressure reduction effect by 0.4% Ripasudil after trabectome - Intraocular pressure reduction effect by 0.4% Ripasudil after trabectome

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028066

Enrollment

Registered

2017-07-07

Start date

2017-07-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Open angle glaucoma patients who are using Ripasudil and satisfy trabectome adaptation criteria during the study period. 2) Patients who have no history of ocular surgery other than cataract surgery. 3) Patients who aged 20 years or older at the time of acquisition. 4) Patient who obtained written consent from the person concerned about participation in this study.

Exclusion criteria

Exclusion criteria: 1) Patients who have history of allergy to Ripasudil. 2) Patients judged inappropriate at the discretion of the research doctor. 3) Patients complicated of clinically serious diseases.

Design outcomes

Primary

Measure	Time frame
Effect of intraocular pressure reduction of Ripasudil just before instillation and 2 hours after instillation after trabectome 1 day, 1 week, and 1, 2,3 months	—

Secondary

Measure	Time frame
Effect of intraocular pressure reduction of Ripasudil just before instillation and 2 hours after instillation before trabectome	—

Countries

Japan

Contacts

Public ContactYUTA SAITO

Showa University School of Medicine, Department of Ophthalmology

s-yuta@med.showa-u.ac.jp03-3784-8553

Outcome results